Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Sanofi

Exchange rates hurt results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi

1Q Revenues: €7.8 billion (-3%)

1Q Earnings: €1.5 billion (-3%)

Comments: Diabetes revenue was up 13% to €1.7 billion. Genzyme revenues were up 22% to €566 million, driven by Aubagio with sales of €78 million versus €20 million in 1Q13. Consumer Healthcare sales were up 19% to €885 million. Sanofi Pasteur vaccine sales were €628 million, down 4%, reflecting a phasing effect in Pentaxim deliveries in Emerging Markets, offset by strong sales for Imovax in Japan and Menactra in the previous year period. Animal Health sales were down 2% to €517 million. Exchange rates had a negative effect of 6% in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters